Assoc. Prof. YÜCEL ERBİLGİN

Publication Network

Articles 39

1. Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling.

Wenson L., Heldin J., Martin M., Erbilgin Y., Salman B., Sundqvist A., et al.

Nature communications , vol.16, no.1, pp.7130, 2025 (SCI-Expanded)

2. **Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients**

Erbilgin Y., Firtina S., Kirat E., Khodzhaev K., Karakas Z., Ünüvar A., et al.

BIOCHEMICAL GENETICS , 2025 (SCI-Expanded, Scopus)

3. Filaggrin Gene Variants Among Patients With Atopic Dermatitis in Turkey: A Multicenter Study Investigating Its Relationship With Disease Severity and Clinical/Laboratory Findings

Erdem Y., Özkaya E., Erbilgin Y., Saritas M., Sayitoğlu M., Kucuk O. S., et al.

DERMATITIS , 2025 (SCI-Expanded, Scopus)

4. A novel germline Pregnane X Receptor (PXR) variant predisposing to Hodgkin lymphoma in two siblings.

Khodzhaev K., Sudutan T., Erbilgin Y., Saritas M., Yegen G., Bozkurt C., et al.

European journal of medical genetics , vol.72, pp.104975, 2024 (SCI-Expanded, Scopus)

5. Mediterranean Journal of Hematology and Infectious Diseases

Qipa E., Acar M., Bozkurt S., Buyukdogan M., Sonmez H. B., Sayitoglu M., et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , no.1, 2023 (SCI-Expanded, Scopus)

6. Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey

Lazic J., Haas O. A., Özbek U., Ripperger T., Byrjalsen A., Te Kronnie G., et al.

Pediatric Blood and Cancer , vol.70, no.5, 2023 (SCI-Expanded)

7. Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.

Firtina S., Erbilgin Y., Hatirnaz Ng O., Karaman S., Karakas Z., Celkan T. T., et al.

Scandinavian journal of clinical and laboratory investigation , vol.83, no.3, pp.187-193, 2023 (SCI-Expanded, Scopus)

8. Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)

Imeri J., Desterke C., Marcoux P., Telliam G., Sanekli S., Barreau S., et al.

Cells , vol.12, no.4, 2023 (SCI-Expanded)

9. Obstacles and expectations of rare disease patients and their families in Turkiye: ISTisNA project survey results

HATIRNAZ NG Ö., Sahin I., ERBİLGİN Y., ÖZDEMİR Ö., YÜCESAN E., Erturk N., et al.

FRONTIERS IN PUBLIC HEALTH , vol.10, 2023 (SCI-Expanded)

10. **Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia.**

Sudutan T., Erbilgin Y., Hatirnaz Ng O., Karaman S., Karakas Z., Kucukcankurt F., et al.

Leukemia & lymphoma , vol.63, no.12, pp.2931-2939, 2022 (SCI-Expanded, Scopus)

11. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia

Erbilgin Y., Hatirnaz Ng O., Can I., Firtina S., Kucukcankurt F., Karaman S., et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , vol.43, no.5, pp.1093-1103, 2021 (SCI-Expanded, Scopus)

12. Differential Expression of LEF1 Isoforms in Adult Lymphoid and Myeloid Malignancies

FIRTINA S., HATIRNAZ NG Ö., ERBİLGİN Y., HAZNEDAROĞLU İ. C., SAYİTOĞLU M.

Experimed , vol.11, 2021 (Peer-Reviewed Journal)

13. HighTUBB2Aexpression in childhood T-ALL is correlated with the clinical outcome

Khodzhaev K., Ng O. H., Tuğcu D., Erbilgin Y., Ng Y. Y., Celkan T., et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , vol.42, no.5, pp.581-588, 2020 (SCI-Expanded)

14. Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect

Khodzhaev K., Bay S., Kebudi R., Altindirek D., Kaya A., Erbilgin Y., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , vol.40, no.6, pp.883-892, 2020 (SCI-Expanded)

15. PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia

Küçükcankurt F., Erbilgin Y., Fırtına S., Hatırnaz N., Karakaş Z., Celkan T., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.37, no.2, pp.98-103, 2020 (SCI-Expanded, Scopus, TRDizin)

16. Prognostic gene alterations and clonal changes in childhood B-ALL

Erbilgin Y., Firtina S., Mercan S., Ng O. H., Karaman S., Tasar O., et al.

LEUKEMIA RESEARCH , vol.83, 2019 (SCI-Expanded, Scopus)

17. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors

Erbilgin Y., Eskazan A. E., Ng O. H., Salihoglu A., Elverdi T., Firtina S., et al.

LEUKEMIA & LYMPHOMA , vol.60, pp.200-207, 2019 (SCI-Expanded)

18. Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.

Ongoren S., Eskazan A. E., Suzan V., Savci S., Ozunal I. E., Berk S., et al.

Hematology (Amsterdam, Netherlands) , vol.23, no.4, pp.212-220, 2018 (SCI-Expanded)

19. Prevalence and effect evaluation of FLT3 and NPM1 mutations in acute myeloid leukemia patients in eastern Algeria

Ayachı O. S., Rezgoun M. L., Sayitoglu M., Altindirek D., Erbilgin Y., Abadı N., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.28, no.3, pp.169-179, 2018 (SCI-Expanded)

20. Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia.

Fırtına S., Hatırnaz N. O., Erbilgin Y., Özbek U., Sayitoğlu M.

Turkish journal of medical sciences , vol.47, pp.357-363, 2017 (SCI-Expanded)

21. Aberrant Hypermethylation of APC Tumor Supressor Gene in Acute Leukemia Patients

Hatirnaz O. N. G., Firtina S., Erbilgin Y., Özbek U., Sayitoglu M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, pp.1-7, 2017 (SCI-Expanded)

22. Çocukluk Çag ı Akut Lenfoblastik Lösemide Genetik Belirteçler

ERBİLGİN Y., ÖZBEK U.

Turkiye Klinikleri J Pediatr Sci , vol.12, no.4, 2016 (Peer-Reviewed Journal)

23. Local Renin-Angiotensin system in normal hematopoietic and multiple myeloma-related progenitor cells.

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.31, no.2, pp.136-42, 2014 (SCI-Expanded)

24. Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia.

Ng O. H., Erbilgin Y., Firtina S., Celkan T., Karakas Z., Aydogan G., et al.

Blood cancer journal , vol.4, 2014 (SCI-Expanded, Scopus) Sustainable Development

25. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders.

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.

Journal of the renin-angiotensin-aldosterone system : JRAAS , vol.14, no.4, pp.308-14, 2013 (SCI-Expanded)

26. Parallel Visualization of Multiple Protein Complexes in Individual Cells in Tumor Tissue

Leuchowius K., Clausson C., Grannas K., Erbilgin Y., Botling J., Zieba A., et al.

MOLECULAR & CELLULAR PROTEOMICS , vol.12, no.6, pp.1563-1571, 2013 (SCI-Expanded) Sustainable Development

27. Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Sayitoglu M., Erbilgin Y., Ng O. H., Yildiz I., Celkan T., Anak S., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.29, no.4, pp.325-33, 2012 (SCI-Expanded)

28. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.

Hannon M. M., Lohan F., Erbilgin Y., Sayitoglu M., O'hagan K., Mills K., et al.

British journal of haematology , vol.158, no.5, pp.626-34, 2012 (SCI-Expanded)

29. Akut lösemi hücre serilerinde beta-katenin sirna uygulamaları

HATIRNAZ O., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

Deneysel Tıp Dergisi , vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

30. Genetic alterations in members of the Wnt pathway in acute leukemia

Erbilgin Y., Ng O. H., Mavi N., Ozbek U., Sayitoglu M.

LEUKEMIA & LYMPHOMA , vol.53, pp.508-510, 2012 (SCI-Expanded)

31. Akut Lösemi Hücre Serilerinde Beta-Katenin siRNA Uygulamaları

HATIRNAZ NG Ö., ERBİLGİN Y., AKTAŞ E., DENİZ G., ÖZBEK U., SAYİTOĞLU M.

Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)

32. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.

Firtina S., Sayitoglu M., Hatirnaz O., Erbilgin Y., Oztunc C., Cinar S., et al.

Leukemia research , vol.36, no.1, pp.87-92, 2012 (SCI-Expanded, Scopus)

33. Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?

Eskazan A. E., Soysal T., Erbilgin Y., Ozbek U., Ferhanoglu B.

LEUKEMIA RESEARCH , vol.35, no.9, 2011 (SCI-Expanded)

34. BETA KATENİN VE AXIN2 PROTEİNLERİ ETKİLEŞİMLERİNİN PROKSİMİTİ LİGASYON ASSAY YAKINSAL BAĞLANMA TESPİTİ ILE GÖRÜNTÜLENMESİ

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., SÖDERBERG O., ÖZBEK U.

DENEYSEL TIP DERGİSİ , vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)

35. ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method

Erbilgin Y., Catal S., Eskazan A. E., Hatirnaz O., Soysal T., Ozbek U.

TURKISH JOURNAL OF HEMATOLOGY , vol.28, no.2, pp.97-102, 2011 (SCI-Expanded)

36. ß Katenin ve Axin2 proteinleri etkileşimlerinin Proksimiti LigasyonAssay Yakınsal Bağlanma Tespiti ile görüntülenmesi

ERBİLGİN Y., SAYİTOĞLU M., SODERBERG O., HATIRNAZ NG Ö., ÖZBEK U.

Deneysel Tıp Dergisi , vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)

37. Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation

Uz B., Bektas O., Eliacik E., GÖKER H., ERBİLGİN Y., SAYİTOĞLU M., et al.

CASE REPORTS IN HEMATOLOGY , 2011 (ESCI)

38. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL

Erbilgin Y., Sayitoglu M., Hatirnaz O., Dogru O., Akçay A., TUYSUZ G., et al.

DISEASE MARKERS , vol.28, no.6, pp.353-360, 2010 (SCI-Expanded)

39. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.

Sayitoglu M., Haznedaroğlu İ. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.

The Journal of international medical research , vol.37, no.4, pp.1018-28, 2009 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 104

1. Deciphering congenital hemolytic anemia: identifying causal variants in unresolved cases through whole exome sequencing

Altındirek D., Tuğcu D., Karaman S., Erbilgin Y., Ünal Cangül Ş., Küpesiz O. A., et al.

European Human Genetics Conference, Milan, Italy, 24 - 27 May 2025, pp.1-2, (Summary Text)

2. HODGKİN LENFOMAYA KALITSAL YATKINLIK OLUŞTURAN YENİ BİR GEN: PREGNANE X RESEPTÖRÜ (PXR)

Sudutan T., Khodzhaev K., ERBİLGİN Y., SARITAŞ M., YEGEN G., Bozkurt C., et al.

50. Ulusal Hematoloji Kongresi, Turkey, 30 October 2024, (Summary Text)

3. Ethical, Legal, and Social ImplicaKons (ELSI) of Biobanking in Turkey

ERBİLGİN Y.

ETHICAL, LEGAL AND SOCIETAL INSIGHTS & OUTLOOK FOR BIOBANKS AND MEDICAL RESEARCH, Lyon, France, 4 - 07 June 2024, (Summary Text)

4. A Novel FBN1 Variant in A Large Marfan Family with High Penetrance of Aortic Features

ERBİLGİN Y., ÇEFLE K., ÖZTÜRK Ş., EKIJI L., KADIOĞLU P., Kocaağa S., et al.

Avrupa İnsan Genetiği Kongresi 2024, Berlin, Germany, 01 June 2024, (Summary Text)

5. ISTisNA Platform: A Comprehensive Biobank Network for Rare and Undiagnosed Diseases

Antmen F. M., KASAP B., Erdogan C., Kılıç M., Kocaaga S., Önder G., et al.

Europe Biobank Week Congress 2024, Viyana, Austria, 14 - 17 May 2024, (Summary Text)

6. Exploring Germline Variations and Predisposition in Childhood Lymphoma

Sudutan T., Khodhzaev K., Erbilgin Y., Altındirek D., Kocaağa S., Sarıtaş M., et al.

Avrupa İnsan Genetiği Kongresi (ESHG), Berlin, Germany, 01 May 2024, (Unpublished)

7. Hereditary hemolytic anemia cases in Turkey by whole exome sequencing

Altındirek D., ERBİLGİN Y., KARAKAŞ Z., KARAMAN S., TUĞCU D., SAYİTOĞLU M.

EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects, Budapest, Hungary, 3 - 04 November 2023, (Full Text)

8. FOLİKÜLER LENFOMALI HASTALARDA FOLİKÜLER SİTOTOKSİK T HÜCRELERİ

Akboğa F., Kuyaş M. İ., Hindilerden F., Yönal Hindilerden İ., Gültürk E., Erbilgin Y., et al.

26. Ulusal İmmünoloji Kongresi, Ankara, Turkey, 11 - 13 November 2023, pp.49, (Summary Text)

9. Nadir Bir Anemi: Konjenital Diseritropoetik Anemi Tip1’de De Novo CDIN1 Gen Varyasyonu ve Birleşik Heterozigotluk

Altındirek D., TUĞCU D., ERBİLGİN Y., KARAMAN S., SAYİTOĞLU M., TANYILDIZ H. G., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, (Summary Text)

10. Foliküler Lenfomalı Hastalarda Foliküler Sitotoksik T Hücre Alt Grupları ve Fonksiyonları

Akboğa F., Kuyaş M. İ., HİNDİLERDEN F., YÖNAL HİNDİLERDEN İ., Gültürk E., ERBİLGİN Y., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)

11. Nadir Bir Anemi: Konjenital Diseritropoetik Anemi Tip1’de De Novo CDIN1 Gen Varyasyonu ve Birleşik Heterozigotluk

Altındirek D., Tuğcu D., Erbilgin Y., Karaman S., Sayitoğlu M., Tanyıldız H. G., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, (Unpublished)

12. Makine Öğrenmesi Temelli Transkriptom Modeli Kullanarak Ph-Benzeri ALL Hastalarının Tespiti

Sun E., ULUCAN AÇAN Ö., ERBİLGİN Y., EŞKAZAN A. E., KARAKAŞ Z., SAYİTOĞLU M.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)

13. Çocukluk Çağı Lenfoma Hastalarında Germline Varyasyonlar ve Genetik Yatkınlık

Khodzhaev K., SUDUTAN T., ERBİLGİN Y., Ocak S., KIYKIM A., Altındirek D., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)

14. Çocukluk Çağı Lenfoma Hastalarında Germline Varyasyonlar ve Genetik Yatkınlık

Khozhaev K., Sudutan T., Erbilgin Y., Ocak S., Kıykım A., Altındirek D., et al.

49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, pp.1-2, (Summary Text)

15. Characterization of Hereditary Hemolytic Anemia cases in Turkey by Whole Exome Sequencing

Altındirek D., Tuğcu D., Karaman S., Erbilgin Y., Sayitoğlu M., Karakaş Z.

EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From Basic Science to Clinical Case Application, Budapest, Hungary, 12 - 14 October 2023, (Unpublished)

16. BCL11b Mutasyonuna Bağlı Kombine İmmün Yetmezliği Olan Bir Hastada Kazanılmış Hemofili

ŞAHİN Ş., KARAMAN S., ERBİLGİN Y., ASLANGER A. D., GEZDİRİCİ A., TUĞCU D., et al.

14. Ulusal Pediatrik Hematoloji Kongresi, Ankara, Turkey, 24 May 2023, (Summary Text)

17. The Anti-HIV Drug Nelfinavir Exhibits Synergistic Activity with Tyrosine Kinase Inhibitors and Circumvents TKI-Resistance Conferred By T315I-Mutated BCR-ABL

ERBİLGİN Y., Desterke C., Bennaceur Griscelli A., TURHAN A.

64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 - 13 December 2022, pp.3871-3872, (Full Text)

18. Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets

Imeri J., Desterke C., Telliam G., Marcoux P., Sorel N., Sanekli S., et al.

64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 December - 13 November 2022, pp.12173-12174, (Summary Text)

19. KRONİK MİYELOİD LÖSEMİ HASTALARINDA FARKLI BCR::ABL1 TRANSKRİPTLERİNİN KLİNİK YANSIMALARI

Ordu M., Erbilgin Y., Yılmaz U., Eşkazan A. E., Altındirek D., Uğur İşeri S. A., et al.

48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, pp.126-127, (Full Text)

20. KONJENİTAL HEMOLİTİK ANEMİ HASTALARINDA TÜM EKZOM DİZİLEME İLE ADAY VARYANTLARIN BELİRLENMESİ

ALTINDİREK D., TUĞCU D., BİLİCİ M., KARAMAN S., ERBİLGİN Y., ÜNAL CANGÜL Ş., et al.

48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2022, (Full Text)

21. ÇOCUKLUK ÇAĞI BİFENOTİPİK AKUT LÖSEMİ HASTALARINDA MOLEKÜLER BELİRTEÇLER VE PROGNOSTİK ÖNEMİ

KÜÇÜKCANKURT F., ERBİLGİN Y., Sudutan T., KARAKAŞ Z., KARAMAN S., ÖZDEMİR G. N., et al.

48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, (Full Text)

22. Lenfoma ve İmmünyetmezliğe Sahip İndeks Olguda Somatik ve Germline Varyasyonların Ekzom Dizi Analizi ile Analizi

Khodzhaev K., SARITAŞ M., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.

XIII. AZİZ SANCAR DENEYSEL TIP ARAŞTIRMA ENSTİTÜSÜ GÜNLERİ Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye, İstanbul, Turkey, 21 - 22 December 2021, vol.12, (Summary Text)

23. A Novel Candidate Gene for Predisposition of Hodgkin Lymphoma; Pregnan X Receptor (PXR)

KEBUDİ R., ERBİLGİN Y., Khodzhaev K., Sarıtaş M., BOZKURT C., SAYİTOĞLU M.

63RD ASH ANNUAL MEETING, United States Of America, 11 December 2021, (Full Text)

24. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia

ERBİLGİN Y., HATIRNAZ NG Ö., FIRTINA S., Küçükcankurt F., KARAKAŞ Z., CELKAN T. T., et al.

European Human Genetics Virtual Conference 2021, Austria, 28 - 31 August 2021, (Summary Text)

25. Wnt Sinyal İleti Yolunun T-Hücreli ve B-Hücreli Akut Lenfoblastik Lösemilerde Farklı Aktivasyonları

SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ERBİLGİN Y., ÖZBEK U.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, pp.75, (Full Text)

26. Gen Ekspresyon Verilerinin Meta-Analizi ile Pediatrik Akut Lenfoblastik Lösemi’xxde Nükse Özgü Belirteçlerin Tespiti

ERBİLGİN Y., Khodzhaev K., SAYİTOĞLU M.

45. Ulusal Hematoloji Kongresi, Turkey, 31 October - 02 November 2019, (Full Text)

27. Akut Lösemili Hastalarda ’xx’xx Zinc Finger Protein 384’xx’xx (ZNF384) Geni Füzyonlarının Tespiti

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., SARPER N., CELKAN T. T., et al.

45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Summary Text)

28. CD70 mutations in a family with affected CID indivuduals

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M.

Highlights of Bertinoro, Predisposition to hereditary Leukemia and Lymphoma Training School, 11 - 12 October 2019, (Full Text)

29. Whole Genome Expression Profiling at Diagnosis Predicts Relapse in Childhood Acute Lymphoblastic Leukemia

ERBİLGİN Y., Khodzhaev K., SAYİTOĞLU M.

7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)

30. Determination of Zinc Finger Protein 384 (ZNF384) Gene Fusion in Childhood Acute Lymphoblastic Leukemia Patients

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAKAŞ Z., SARPER N., CELKAN T. T., et al.

13th Balkan Congress of Human Genetics, 17 - 20 April 2019, (Full Text)

31. T-akut lenfoblastik lösemi (T-ALL) Hastalarında Yüksek TUBB2A Gen Anlatımı ve siRNA Aracılı Modülasyonu

Khodzhaev K., HATIRNAZ NG Ö., TUĞCU D., Ng Y. Y., ERBİLGİN Y., CELKAN T. T., et al.

13. Ulusal Tıbbi Genetik Kongresi, Turkey, 7 November - 11 October 2018, (Summary Text)

32. Kanda serbest dolaşan tümör cDNA’larının lenfoma alt gruplarının tanımlanmasında ve hastalık takibinde kullanımının araştırılması

ERBİLGİN Y.

44.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)

33. A translational perspective on diffuse large B-cell lymphoma

Erbilgin Y.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

34. Comprehensive analysis of transcriptomic portrait of T-cell acute lymphoblastic leukemia by RNA sequencing

Sun E., Ng O. H., Erbilgin Y., Firtina S., Sayitoglu M.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

35. Nörogenetik verinin analizi: İnteraktif eğitim ve uygulama- ACMG Klavuzu

ERBİLGİN Y.

Nadir Görülen Hastalıklar Sempozyumu ve Nörogenetik Kursu, Turkey, 31 May 2018, (Summary Text)

36. AccessDistribution of Biospecimens: Practical Issues

ERBİLGİN Y.

International Workshop on Biobanking for Rare Diseases, 2 - 03 May 2018, (Full Text)

37. IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Erbilgin Y., Firtina S., NG O. H., CELKAN T., Karakas Z., Anak S. S., et al.

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)

38. Çocukluk Çağı B-All Gelişiminde Kanonik Olmayan Wnt Yolağı Prognoz ve Sağ Kalım İle İlişkili Olabilir

HATIRNAZ N. Ö., FIRTINA S., AKGÜN E., TAKA E., ERBİLGİN Y., CELKAN T. T., et al.

43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

39. Çocukluk Çağı B-All Hastalarında Tanı Ve Nüks Anındaki Moleküler Değişimlerin Dinamiği

FIRTINA S., ERBİLGİN Y., TAŞAR O., MERCAN S., HATIRNAZ N. Ö., şişko s., et al.

43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

40. Çocukluk Çağı B-ALL Hastalarında IKZF1 Delesyonlarının Araştırılması

ERBİLGİN Y., FIRTINA S., khodzhaev k., HATIRNAZ N. Ö., KARAKAŞ Z., CELKAN T. T., et al.

43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

41. Çocukluk Çağı B-ALL Hastalarinda IKZF1 Delesyonlarinin Araştırılması

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., ÖZBEK U.

43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

42. Çocukluk Çağı T Hücreli Akut Lenfoblastik Lösemi Hastalarında Artmış TUBB2A Anlatımı Tedavi Yanıtını Belirler

KHODZHAEV K., HATIRNAZ NG Ö., TUĞCU D., ERBİLGİN Y., CELKAN T. T., KARAKAŞ Z., et al.

43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

43. C¸OCUKLUK C¸AGˆI B-ALL HASTALARINDA IKZF1 DELESYONLARININ ARAS¸TIRILMASI

ERBİLGİN Y., Firtina S., Khodzhaev K., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T., et al.

43 Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.13, (Summary Text)

44. T-AKUT LENFOBLASTİK LÖSEMİ’DE TRANSKRİPTOM DİZİLEME ANALİZLERİ

Sun E., HATIRNAZ NG Ö., Firtina S., ERBİLGİN Y., SAYİTOĞLU M.

50. Ulusal Hematoloji KOngresi, Antalya, Turkey, 1 - 04 November 2017, pp.12, (Full Text)

45. Research Biobank for Leukemia

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., khodzhaev k., ÖZBEK U., SAYİTOĞLU M.

Towards Harmony in Biobanking, 13 - 15 September 2017, (Summary Text)

46. Outcomes of a Biobanking Initiative from Turkey: ‘Investing in the Future: BIOBANK

ERBİLGİN Y., TUNCER F. N., UĞUR İŞERİ S. A., Khodzhaev K., ÖZBEK U.

Global Biobank Week, 13 - 15 September 2017, (Summary Text)

47. Towards an Epilepsy Biobank

Haryanyan G., Özdemir Ö., Yücesan E., TUNCER F. N., Kesim F. Y., ERBİLGİN Y., et al.

Global Biobank Week, 13 - 15 September 2017, (Summary Text)

48. Does TUBB2A expression have a prognostic effect in childhood T-ALL patients

Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.

6th International Congress on Leukemia Lymphoma Myeloma, 11 - 16 May 2017, (Summary Text)

49. PTEN AND AKT1 GENE VARIATIONS IN CHILDHOODT-ALL PATIENTS

Küçükcankurt F., HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., KARAKAŞ Z., CELKAN T. T., et al.

6th International Congress onLeukemia – Lymphoma – Myeloma, 11 - 13 May 2017, (Summary Text)

50. Comparative analysis of regenerative potential of dental pulp and dental follicle derived stem cells cultured on polycaprolactone scaffolds for bone tissue engineering approaches

Özcan E., ERBİLGİN Y.

23rd International Conference on Oral and Maxillofacial Surgery, 31 March - 03 April 2017, (Summary Text)

51. Pediatrik T ALL hastalarında regulator mikroRNA ların yolak analizleri ile belirlenmesi

HATIRNAZ NG Ö., Khodzhaev K., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

42 Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016, (Full Text)

52. Pre examination process requirements for European biobanks focus on venous whole blood

Linsen L., Baber R., Caboux E., Daidone M., ERBİLGİN Y., wilde A. D., et al.

European Biobank Week 2016, 13 - 16 September 2016

53. Investing in the Future BIOBANK

ERBİLGİN Y., TUNCER F. N., Haryanyan G., Khodzhaev K., UĞUR İŞERİ S. A., ÖZBEK U.

European Biobank Week 2016, 13 - 16 September 2016

54. General quality management system requirements for European biobanks focus on formalin fixed and paraffin embedded tissues

Bonin S., Stumptner C., Caboux E., wilde A. D., ERBİLGİN Y., Goethals S., et al.

European Biobank Week 2016, 13 - 16 September 2016

55. Improve human derived sample quality grade in European biobanks focus on snap frozen tissues on behalf of BBMRI ERIC Working Group 1 in the Work plan Quality

Daidone M., Baldacchio S., Barros F., Becker K., Caboux E., wilde M. D., et al.

European Biobank Week 2016, 13 - 16 September 2016

56. Biyobankalarda Pre Analitik Süreçler ve Standartlar

ERBİLGİN Y.

Biyobankada Laboratuvar Süreçleri Kursu, Turkey, 27 May - 28 June 2016

57. Pathway Analizi Enrichment Analizi

ERBİLGİN Y.

Biyobankalamada Veri Analizi Yöntemleri Kursu, Turkey, 30 - 31 May 2016

58. Gen expression paterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets

ERBİLGİN Y., İŞLEK B., FIRTINA S., HATIRNAZ NG Ö., İNAL A., DOĞAN P., et al.

ESHG, 24 - 27 May 2016, (Summary Text)

59. Gene expression patterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets

ERBİLGİN Y., İşlek B., Fırtına S., HATIRNAZ NG Ö., İnal A., Doğan P., et al.

European Society of Human Genetics 2016, Barselona, Spain, 21 - 24 April 2016, (Summary Text) Sustainable Development

60. Gene expression pattern in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targetss

ERBİLGİN Y., İslek B., Firtina S., HATIRNAZ NG Ö., Inal A., Dogan P., et al.

ESHG, Barselona, Spain, 20 - 22 May 2016, (Summary Text)

61. PROGNOSTİC SİGNİFİCANCE OF IKZF1 DELETİONS İN CHİLDHOOD B ALL

ERBİLGİN Y., FIRTINA S., HATIRNAZ NG Ö., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

Bİ ANNUAL CHILDHOOD LEUKEMIA SYMPOSIUM, 25 April - 27 May 2016, (Summary Text)

62. Prognostic significance of IKZF1 Deletionsin Childhood B ALL

ERBİLGİN Y., Fırtına S., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T. T., SARPER N., et al.

10.th Biennial Childhood Leukemia Sypmosium, 24 - 26 April 2016, (Summary Text)

63. Geleceğe Yatırım BİYOBANKA Projesi kapsamında Biyobankalama Protokolleri

ERBİLGİN Y.

Biyobankada Protokol ve Kalite Çalıştayı, Turkey, 06 April 2016

64. Hematolojik malignitelerde genetik belirteçler

ERBİLGİN Y., ÖZBEK U.

Ulusal Çocuk Genetik Sempozyumu, Turkey, 22 - 24 October 2015

65. Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study

SOVERINI S., ERNST T., KOHLMANN A., DE BENEDITTIS C., ALIKIAN M., FORONI L., et al.

55.th ASH Meeting 2013, 7 - 10 December 2013, vol.122

66. Pediatrik T ALL hastalarında regülatör mikroRNA ların yolak analizleri ile belirlenmesi

HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.

14 Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2015, (Summary Text)

67. Pathways associated with relapse and high risk in childhood acute lymphoblastic leukemia

ERBİLGİN Y.

European Society of Human Genetics, Glasgow, United Kingdom, 6 - 09 June 2015, pp.445, (Full Text)

68. Downregulation of SnoN SKIL gene in T ALL

HATIRNAZ NG Ö., Orcun T., Yuk Yin N., ceren o., ERBİLGİN Y., SAYİTOĞLU M., et al.

European Society of Human Genetics Meeting, Glasgow, England, 6 - 09 June 2015

69. Pathways associated with relapse and high risk in childhood ALL

ERBİLGİN Y., HATIRNAZ NG Ö., Burak İ., Sinem F., Tiraje C., ANAK S. S., et al.

European Society of Human Genetics Meeting, Glasgow, England, 6 - 09 June 2015

70. Pathways asociated with relapse and high risk in childhood acute lymphoblastic leukemia

ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., ANAK S. S., KARAKAŞ Z., SARPER N., et al.

ESHG 2015, 6 - 09 June 2015

71. Down regulation of SnoN SKIL gene in T cell acute lymphoblastic leukemia

HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M., ÖZBEK U.

ESHG 2015, 6 - 09 June 2015

72. Downregulation of Sno SKIL gene in T ALL

HATIRNAZ NG Ö., Orcun T., Yuk Yin N., Ceren Ö., ERBİLGİN Y., SAYİTOĞLU M., et al.

5th International Leukemia Lymphoma Myeloma Meeting, İstanbul, Turkey, 21 - 23 May 2015

73. PATHWAYS ASSOCIATED WITH RELAPSE AND HIGH RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

ERBİLGİN Y., HATIRNAZ NG O., ISLEK B., FIRTINA S., CELKAN T. T., ANAK S. S., et al.

EUROPEAN HUMAN GENETICS CONFERENCE 2015 GLASGOW, SCOTLAND, UK, 6 - 09 June 2015, vol.23, (Full Text)

74. Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom Analizleri

ERBİLGİN Y.

DETAE Genç Araştırıcılar Toplantısı, Turkey, 19 - 20 January 2015, (Summary Text)

75. İÜ DETAE MOLEKÜLER HEMATOLOJİ ÇALIŞMA GRUBU 1996 2014 YILLARI LÖSEMİLERİN MOLEKÜLER MONİTORİZASYONU

SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., ALTINDİREK D., SERBEST E., SIRMA EKMEKCİ S., et al.

6. DETAE GÜNLERİ, Turkey, 24 - 25 November 2014

76. Pediatrik Akut Lösemi Hastalarında LEF1 Mutasyon Analizi

TOZAN F., ERBİLGİN Y., CAN İ., HATIRNAZ N. Ö., TAŞAR O., MERCAN S., et al.

6. DETAE Günleri, Turkey, 24 - 25 November 2014, (Summary Text)

77. Pediatrik ALL Hastalarında LEF1 Mutasyon Analizi

KÜÇÜKCANKURT F., ERBİLGİN Y., CAN İ., HATIRNAZ N. Ö., MERCAN S., şişko s., et al.

40. Ulusal Hematoloji Kongresi, Turkey, 22 - 25 October 2014, (Summary Text)

78. ÇOCUKLUK ÇAĞI NÜKS AKUT LÖSEMİDE GENOM BOYU METİLASYON ANALİZLERİ

ERBİLGİN Y., HATIRNAZ NG Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

40. Ulusal Hematoloji Kongresi, Turkey, 22 October 2014, (Summary Text)

79. Epigenetic profile of early relapsed Childhood ALL

ERBİLGİN Y., AYDOGAN G., CELKAN T., SAYİTOĞLU M., HATIRNAZ N. Ö., KARAKAŞ Z., et al.

40 Ulusal Hematoloji Kongresi, Antalya, Turkey, 22 - 25 October 2014, pp.20, (Summary Text)

80. Next Generation Sequencing Of The BCR ABL1 Domain May Be Beneficial In Decision Makin

Emre E., ÖZBEK U., HATIRNAZ NG Ö., ERBİLGİN Y., SOYSAL T., SAYİTOĞLU M., et al.

55th Annual Meeting of the American-Society-of-Hematology, New Orleans, United States Of America, 7 - 10 December 2013, (Full Text)

81. Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Erbilgin Y., Eskazan A. E., NG O. H., Salihoglu A., Elverdi T., Firtina S., et al.

55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text)

82. Derin Dizi Analizi ile Pediatrik Akut Lenfoblastik Lösemi Hastalarında TP53 Gen Mutasyonlarının Saptanması ve Prognostik Önemi

FIRTINA S., ERBİLGİN Y., HATIRNAZ N. Ö., CAN İ., KARAKAŞ Z., CELKAN T. T., et al.

39. Ulusal Hematoloji Kongresi, Turkey, 23 - 26 October 2013, (Summary Text)

83. Çocuk Çağı Nüks Akut Lösemi Hastalarının Genetik ve Epigenetik Karakterizasyonu

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

39. Ulusal Hematoloji Kongresi, Turkey, 23 - 26 October 2013, (Summary Text)

84. TİROZİN KİNAZ İNHİBİTÖRLERİNE DİRENÇLİ KRONİK MİYELOİD LÖSEMİ HASTALARINDA YENİ NESİL DİZİLEME TEKNİĞİ İLE BCR-ABL1 KİNAZ BÖLGESİ MUTASYONLARININ TESPİTİ

ERBİLGİN Y., EŞKAZAN A. E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., FIRTINA S., et al.

39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 October 2013, (Summary Text)

85. Whole genome methylation profile of relapsed childhood leukemia, Translating Epigenomes into Function: a Next-Generation Challenge for Human Disease

ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.

FEBS Workshop, Germany, 13 - 16 October 2013, (Summary Text)

86. Normalization methods and analysis packages for 450k data analysis

ERBİLGİN Y.

High-Throughput Methylome Analysis & Its Impact on Human Health and Disease Workshop, İstanbul, Turkey, 31 May 2013, (Summary Text)

87. Yeni nesil dizileme yöntemi ile tanı ve nüks akut lösemi hastalarında Tp53 Mutasyonlarının araştırılması

FIRTINA S., CAN İ., HATIRNAZ N. Ö., ERBİLGİN Y., KARAKAŞ Z., CELKAN T. T., et al.

9. Ulusal Pediatrik Hematoloji Kongresi, Turkey, 24 - 28 May 2013, (Summary Text)

88. Çocukluk Çağı Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom SNP Array Analizi

ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., FIRTINA S., Can İ., ÜNÜVAR A., et al.

9 Ulusal Pediatrik Hematoloji Kongresi, Van, Turkey, 24 May 2013, pp.8, (Summary Text)

89. Elevated Trib2 with Notch1 activation in pediatric adult T ALL

ERBİLGİN Y., ÖZBEK U., M Hannon M., Lohan F., O Hagan K., Mills K., et al.

BRITISH JOURNAL OF HAEMATOLOGY, Glasgow, England, 2 - 04 December 2012, vol.157, pp.6, (Summary Text)

90. Çocukluk Çağı Nüks Akut Lösemi Hastalarında Tüm Genom Analizleri Ön Bulgular

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ N. Ö., FIRTINA S., ÖZGÜVEN A. A., AĞAOĞLU L., et al.

38. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012, (Summary Text)

91. ÇOCUKLUK ÇAĞI NÜKS AKUT LÖSEMİ HASTALARINDA TÜM GENOM ANALİZLERİ; ÖN BULGULAR

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., FIRTINA S., ÖZGÜVEN A. A., AĞAOĞLU ÜLGÜR F. L., et al.

38 Ulusal Hematoloji Kongresi, Turkey, 31 October 2012, (Summary Text)

92. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia

FIRTINA S., SAYİTOĞLU M., HATIRNAZ N. Ö., ERBİLGİN Y., ÖZTUNÇ C., ÇINAR S., et al.

Molecular Immunology Immunogenetics Congress, Turkey, 27 - 29 April 2012, (Summary Text)

93. BCR-ABL TRANSKRİPTİNİN KANTİTATİF TAYİNİNDE ULUSLARARASI SKALAYA GEÇİŞ

HATIRNAZ NG Ö., ERBİLGİN Y., Çatal S., Öztunç C., Uğurel E., KARABULUT A., et al.

37. Ulusal Hematoloji Kongresi, Antalya, Turkey, 19 - 22 October 2011, (Summary Text)

94. A new noncoding risk factor for ALL 8q24 region preliminary data

Ismail C., HATIRNAZ NG Ö., ERBİLGİN Y., Ceren O., SAYİTOĞLU M., ugur o., et al.

3rd EMBO meeting, Viyana, Austria, 11 - 13 September 2011

95. Mutations in AXIN1, APC and B-catenin Genes in T-cell Acute Leukemia Patients

SAYİTOĞLU M., ÖZBEK U., ERBİLGİN Y.

T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development, Mandelieu, France, 7 - 09 May 2010, pp.28, (Full Text)

96. B HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ HASTALARINDA PAX5 GENİ MOLEKÜLER ANALİZLERİ

ÖZDEMİRLİ S., SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., MAVİ N., TİMUR Ç., et al.

35.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 7 - 10 November 2009

97. T-ALL OLGULARINDA NOTCH1 VE FBXW7 GEN MUTASYONLARININ ARAŞTIRILMASI

ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., AR M. C., DOĞRU Ö., Aydoğan G., et al.

35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 07 October 2009, (Summary Text)

98. Increased level of B-catenin mRNA and mutational alterations in APC gene are present in acute leukemia

ATALAR F., Sayitoglu M., HATIMAZ O., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.62, (Summary Text)

99. Methylation status of the wnt antagonist DICKKOPF-1 gene in acute leukemias

ATALAR F., HATIRNAZ O., Sayitoglu M., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.403, (Summary Text)

100. WNT5A gene expression and promoter methylation in acute leukemia patients

HATIMAZ O., Sayitoglu M., ATALAR F., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)

101. WNT pathway mutations in acute leukemia patients

Sayitoglu M., HATIMAZ O., ATALAR F., ERBILGIN Y., OZBEK U.

12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)

102. Upregulation of FZ5 results in abberant expression of beta-catenin and LEF/TCF complex in acute myeloid leukemia.

Atalar F., Hatirnaz O., Erbilgin Y., Ozbek U., Sayitoglu M., Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108

103. Different activation of WNT signaling pathway in B-cell and T-cell acute leukemias.

Sayitoglu M., HATIRNAZ O., Erbilgin Y., Atalar F., Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)

104. Yüksek FZ5 Ekspresyonu Beta-Catenin/TCF-LEF Kompleksinin Atipik Ekspresyonunu Arttırarak Akut Myeloid Lösemi Gelişiminde Rol Oynar

Atalar F., Sayitoğlu M., Hatirnaz Ng Ö., Erbilgin Y., Özbek U.

XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 8 - 12 November 2006, pp.76, (Full Text)

Books 9

Metrics

Publication

152

Publication (WoS)

Publication (Scopus)

Citation (WoS)

307

H-Index (WoS)

Citation (Scopus)

319

H-Index (Scopus)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works